Moving Beyond Topical Treatments in Atopic Dermatitis Management

Panelists discuss how systemic treatments for moderate to severe atopic dermatitis offer significant advantages over topicals, including more comprehensive disease control, improved adherence, reduced treatment burden, greater efficacy for widespread disease, ability to address immunological drivers of inflammation, prevention of flares, management of both cutaneous and extracutaneous manifestations, reduced corticosteroid exposure, and potential modification of disease trajectory—particularly benefiting patients with extensive involvement, recalcitrant disease, or whose quality of life has been highly affected.